Pub. Date : 2015 Dec
PMID : 26254860
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | T1-11 and JMF1907 ameliorate polyglutamine-expanded ataxin-3-induced neurodegeneration, transcriptional dysregulation and ataxic symptom in the SCA3 transgenic mouse. | polyglutamine | ataxin 3 | Mus musculus |
| 2 | T1-11 and JMF1907 ameliorate polyglutamine-expanded ataxin-3-induced neurodegeneration, transcriptional dysregulation and ataxic symptom in the SCA3 transgenic mouse. | polyglutamine | ataxin 3 | Mus musculus |
| 3 | More studies are required to develop therapeutic agents for treating spinocerebellar ataxia type 3 (SCA3), which is caused by mutant polyglutamine-expanded ataxin-3 and is the most prevalent subtype of spinocerebellar ataxias. | polyglutamine | ataxin 3 | Mus musculus |
| 4 | More studies are required to develop therapeutic agents for treating spinocerebellar ataxia type 3 (SCA3), which is caused by mutant polyglutamine-expanded ataxin-3 and is the most prevalent subtype of spinocerebellar ataxias. | polyglutamine | ataxin 3 | Mus musculus |
| 5 | More studies are required to develop therapeutic agents for treating spinocerebellar ataxia type 3 (SCA3), which is caused by mutant polyglutamine-expanded ataxin-3 and is the most prevalent subtype of spinocerebellar ataxias. | polyglutamine | ataxin 3 | Mus musculus |